Un nuevo estudio, publicado en PLoS One, ha demostrado la efectividad del fármaco CORM-2, basado en moléculas liberadoras de monóxido de carbono, para el tratamiento de la neuropatía diabética en...
Read moreThe JRC just released a report clarifying the key concepts and terms used in the European Commission's nanomaterial definition.
Read moreEl Congreso de familias y profesionales GLUT1DS, organizado por la asociación de afectados por esta enfermedad rara (aGLUTinate) y el CIBERER en el Hospital Niño Jesús de Madrid, congregó a un ele...
Read moreLa Clínica Universidad de Navarra inicia un ensayo clínico para probar la eficacia de un fármaco contra la primera causa de pérdida visual en pacientes con diabetes mellitus
Read moreUn grupo de investigadores de la Escuela Técnica Superior de Ingeniería de la Universidad de Sevilla obtiene filamentos y fibras a partir de líquidos altamente viscosos con tecnología que genera...
Read moreA team of CiQUS (Universidade de Santiago) develops an intelligent nanomaterial that releases drugs inside the cell in a controlled manner when illuminated. The properties of this new porous material ...
Read moreLa UPV desarrolla, en colaboración con la empresa valenciana Hemp Trading, la primera variedad de cannabis legal con alto potencial medicinal
Read moreAbilityPharma (Ability Pharmaceuticals, SL) a biopharmaceutical company developing oncology drugs, announced today that the company will release the first results of the currently ongoing phase 1/2...
Read moreThe European Medicines Agency (EMA) released a draft guideline on the quality requirements for medical devices (MD) in human medicines that include a MD (known as drug device combinations or DDC) f...
Read moreEl portal de referencia sobre enfermedades raras Orphanet ha actualizado dos de sus listados, el informe sobre medicamentos para enfermedades raras en Europa y el de expertos que contribuyeron en la e...
Read moreThe biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in complian...
Read moreThe Food and Drug Administration (FDA) announced its intention to clean the drug listing database from outdated and uncertified records. This action is not limited only to listings for finished dru...
Read more